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Background: The prevention of mother-to-child transmission (PMTCT) program in South Africa is now successful in
ensuring HIV-free survival for most HIV-exposed children, but gaps in PMTCT coverage remain. The study objective
was to identify missed opportunities for prevention of mother-to-child transmission of HIV using the four PMTCT
stages outlined in National Guidelines.
Methods: This descriptive study enrolled HIV-exposed children who were below the age of 7 years and therefore
born during the South African PMTCT era. The study site was in Gauteng, South Africa and enrolment was from
June 2009 to May 2010. The clinical history was obtained through a structured caregiver interview and review of
medical records and included socio-demographic data, medical history, HIV interventions, infant feeding information
and HIV results. The study group was divided into the “single dose nevirapine” (“sdNVP”) and “dual-therapy” (nevirapine
& zidovudine) groups due to PMTCT program change in February 2008, with subsequent comparison between the
groups regarding PMTCT steps during the preconception stage, antenatal care, labor and delivery and postpartum care.
Results: Two-hundred-and-one HIV-exposed children were enrolled: 137 (68%) children were HIV infected and 64
(32%) were HIV uninfected. All children were born between 2002 and 2009, with 78 (39%) in the “sdNVP” and 123 (61%)
in the “dual-therapy” groups. The results demonstrate significant improvements in antenatal HIV testing and PMTCT
enrolment, known maternal HIV diagnosis at delivery, mother-infant antiretroviral interventions, infant HIV-diagnosis
and cotrimoxazole prophylaxis. Missed opportunities without improvement include pre-conceptual HIV-services and
family planning, tuberculosis screening, HIV disclosure, psychosocial support and postnatal care. Not receiving
consistent infant feeding messaging was the only PMTCT component that worsened over time.
Conclusions: Multiple missed opportunities for optimal PMTCT were identified, which collectively increase children’s
risk of HIV acquisition. Although HIV-testing and antiretroviral interventions improved, all PMTCT components need to
be optimized to reach the goal of total pediatric HIV elimination.
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The prevention of HIV transmission to children has be-
come an achievable goal, even in high-prevalence coun-
tries like South Africa, where almost one third of all
children are born to HIV-infected mothers. This pro-
spect of pediatric HIV elimination is attributable to con-
tinued advances in the prevention of mother-to-child
transmission (PMTCT) program, resulting in reduced
numbers of infant HIV infections and improved out-
comes for mother-infant pairs [1].* Correspondence: ute.feucht@up.ac.za
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unless otherwise stated.The South African PMTCT program was implemented in
2002 [2,3], initially using single-dose nevirapine (“sdNVP”)
at the time of delivery for both mother and baby, with the
addition in April 2004 of antiretroviral therapy (ART) for
women with severe HIV disease, as part of the country-
wide ART rollout. Severe disease was classified as World
Health Organization (WHO) stage 4 disease or a CD4
count ≤200 cells/μl [4]. The PMTCT program was revised
in 2008 [5], when the antiretroviral strategy changed to
“dual-therapy”, with the addition of antenatal (third tri-
mester) and postnatal (infant) zidovudine (AZT). Al-
though ART initiation criteria remained unchanged, more
focus was placed on expanding access to maternal tripleThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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PMTCT stages were defined: preconception (stage 1),
antenatal period (stage 2), labor and delivery (stage 3) and
postnatal period (stage 4); the last-mentioned of these four
including the early identification of HIV-infected children
to ensure optimal survival. PMTCT program revision again
occurred in 2010, extending antenatal zidovudine to the
second trimester, elevating the maternal CD4 threshold
for ART eligibility to 350 cells/μl and including WHO
stage 3 disease, and the addition of ART prophylaxis dur-
ing breastfeeding [6]. Since 2013 South Africa has moved
to triple-ART interventions during pregnancy and breast-
feeding for all mothers. There is also a movement towards
improved integration of PMTCT interventions into rou-
tine maternal- and child-health services [7].
PMTCT interventions are highly effective, with HIV-
transmission rates of <5% achievable even in breastfeed-
ing populations [8]. PMTCT being a multistep program
may have its disadvantages, though, as quality assurance
and continuity of care are necessary along the entire
pathway [9-11]. The study aim was to investigate poten-
tial missed opportunities in PMTCT, as well as to com-
pare the intervention coverage in the early sdNVP era
with the subsequent dual-therapy period. The identifica-
tion of potential problematic areas may assist in improv-
ing PMTCT implementation to ensure further reduction
in HIV transmissions with improved outcomes for af-
fected mothers-infant pairs.
Methods
This descriptive study was conducted between June 2009
and May 2010 at Kalafong Hospital in Gauteng, South
Africa. HIV-infected- and HIV-exposed-but-uninfected
children below the age of 7 years, who were in care at
the hospital’s pediatric services, were recruited, as they
had been born during the South African PMTCT era. A
detailed clinical history was obtained by conducting a
structured interview with the primary caregiver using a
questionnaire designed to describe the mother-infant’s
path through the four PMTCT stages, with emphasis on
missed opportunities (preconception advice, maternal HIV
diagnosis, medical interventions, psychosocial support,
feeding counseling and infant follow-up). See Additional
file 1. Additional relevant information was obtained from
the child’s medical records, including hospital records
and the patient-held Road-to-Health Card, in addition to
maternal medical records if these were available. Data col-
lected from the health records included socio-demographic
data, medical history of the mother and child, HIV inter-
ventions and infant feeding information. Furthermore we
reviewed the National Health Laboratory Service database
for the HIV results of study participants.
The study group was divided into two groups, based on
the PMTCT program at the time: The “sdNVP” group,born before February 2008, and the “dual-therapy” group
born thereafter. Missed opportunities were identified and
grouped together for descriptive purposes. Antenatal ART
and postnatal ART prophylaxis had not been part of
PMTCT from 2002 to 2007 and were therefore not in-
cluded as missed opportunities in the comparison of the
two cohorts.
The Ethics Review Committee, Faculty of Health Sci-
ences, University of Pretoria, approved the study protocol.
Descriptive statistics were used to describe participants’
characteristics and missed PMTCT opportunities. Statis-
tical analysis was performed using SPSS® version 20.
Categorical variables were examined using two-sided chi-
square or Fisher’s exact tests, with p-values ≤0.05 consid-
ered significant.
Results
Two-hundred-and-one HIV-exposed children were en-
rolled: 137 children (68%) were HIV infected and 64
(32%) were HIV uninfected, and all born between 2002
and 2009. There were 75 (37%) in the “sdNVP” group
and 126 (63%) in the “dual-therapy” group. For socio-
demographic and medical characteristics of the study
population see Table 1.
At study enrolment, 13 mothers (6%) had died, and
16% of children were cared for by someone other than
their mother. The maternal CD4 count was known in
58%, with 17% on ART, while 16% had been treated for
tuberculosis (TB). Almost half of caregivers (48%) re-
ported previous treatment by traditional healers. The
mean maternal age at the child’s birth had been 27 years
(range 16–46 years), and 32 years (range 18–64 years)
for fathers. Twenty-four fathers (12%) had died, two
were clinically unwell, and in 8% of cases the father’s
whereabouts was unknown. Only 52 fathers (26%) were
known to be HIV positive, with 10% on ART. Caregivers
knew the father’s CD4 count in 7 cases (3%) and 6% re-
ported paternal TB treatment. One-hundred-and-thirty-
eight study participants (69%) had siblings, but in 61% of
these families none of the siblings had been tested for
HIV. Five siblings were HIV positive, two of them re-
ceiving ART, while 6 siblings were reported unwell. An-
other 7 siblings had died, of which 6 deaths had been
HIV-related, while the seventh child had died in a motor
vehicle accident.
Missed opportunities
Missed opportunities were identified in all four PMTCT
stages and are shown in Figure 1 and discussed compar-
ing the “sdNVP” and “dual-therapy” groups.
Preconception care
Pre-conceptual PMTCT components include identifica-
tion and education of HIV-infected women of childbearing
Table 1 Socio-demographic and medical characteristics of
the study population (n = 201)
Housing information • Permanent brick structure 119 (59%)
• Running water indoors 93 (46%)




• Regular income employment 92 (46%)





used for travel to
health services
• Public transport/communal taxi 191 (95%)
• Private transport 9 (4.5%)
• Travel on foot 1 (0.5 %)
Child’s rank
within family
• 1st child 71 (35%)
• 2nd child 72 (36%)
• 3rd child or more 58 (29%)
Antenatal care • None 8 (4%)
• One to three visits 66 (33%)
• Four to six visits 101 (50%)
• Seven visits and more 26 (13%)
Maternal HIV test* • Before pregnancy 32 (16%)
• First trimester 33 (16.5%)
• Second trimester 102 (51%)
• Third trimester 10 (5%)
• After pregnancy 23 (11.5%)
Paternal HIV status • Positive 52 (26%)
• Negative 4 (2%)
• Never tested/unknown 145 (72%)
Place of delivery • Health care facility 192 (96%)
• Home 9 (4%)
Type of delivery • Normal vaginal delivery 142 (71%)
• Cesarean section 59 (29%)
Birth weight** • Less than 2.5 kg 23 (11%)
• 2.5 - 4 kg 172 (86%)
• More than 4 kg 5 (3%)
Infant feeding
choice at the time
of delivery
• Exclusive breastfeeding 135 (67%)
• Formula feeding 66 (33%)
*One case excluded as timing of maternal HIV test unknown.
**One case excluded as birth weight unknown.
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nancies and HIV transmission. The HIV status of 88% of
“sdNVP-” and 82% of “dual-therapy” mothers had been
unknown prior to conception, which was comparable be-
tween the groups (p = 0.24; NS). Thirty-two mothers had
known their HIV status before pregnancy, including seven
who had had no pre-conceptual counseling regarding the
possibility of HIV transmission, nor regarding risk-
reduction strategies. No significant improvements existed
in the other two pre-conceptual care activities assessed as,in total, 123 of the pregnancies (62%) had been unplanned
or unwanted (p = 0.60; NS), while mothers reported barriers
to family planning services in 35% of cases (“sdNVP” =
33% (25/75); “dual-therapy” = 36% (45/126); p = 0.68, NS).
Antenatal care
The second PMTCT stage focuses on identification of
HIV-infected pregnant women and the provision of ap-
propriate antenatal healthcare. Antenatal care attend-
ance had been high, with both groups having had only
four mothers not in care (p = 0.48, NS). Almost two-thirds
(63%) had had at least four antenatal visits, with ample op-
portunity for PMTCT enrolment. The majority of mater-
nal HIV tests had been done in the second trimester
(51%). Mothers for whom no antenatal HIV test had been
done decreased significantly from 42% in the “sdNVP”
group to 12% in the “dual-therapy” group (p < 0.001).
Fifteen mothers had had inadequate post-test counseling,
with no significant differences between the two groups
(p = 0.76, NS).
Antenatal CD4 counts had not been taken in 65% of
HIV-positive mothers in the “sdNVP” group – a missed
opportunity – but this percentage significantly improved
to 35% in the “dual-therapy” group (p < 0.001). The me-
dian waiting time for CD4 results had been 4 weeks.
Fifteen mothers (7%) reported that no information had
been given regarding the importance of the CD4 count,
while seven mothers had never received their CD4 re-
sults. Two mothers from the “sdNVP” group had started
ART during pregnancy, with one already on ART prior
to conception. In the “dual-therapy” group, 36% of
mothers had received AZT from 28 weeks, while 2% had
started on ART and another 2% had never returned for
treatment initiation. Screening for TB had not been car-
ried out in 67% and 66% of mothers in the respective
groups (p = 0.94, NS).
Non-disclosure of their HIV status was reported by
62% of “sdNVP” mothers, comparable to 65% in the sub-
sequent period (p = 0.71, NS), while psychosocial sup-
port had not been offered to 83% and 73% respectively
(p = 0.13, NS). Mothers reported no antenatal infant
feeding counseling in 40% of the “sdNVP” group, with
significant improvement to 18% in the “dual-therapy”
group (p = 0.001).
Labor and delivery
The aim of the third PMTCT stage is to minimize the
risk of HIV transmission during labor and delivery. The
majority of births (96%) had occurred within healthcare
facilities, but in 40% the health workers attending to the
delivery had been unaware of the maternal HIV infec-
tion, a missed opportunity that significantly improved
from 60% (45/75 “sdNVP”) to 24% (30/126 “dual-ther-
apy”) (p < 0.001). ART at time of delivery had not been
Symbols:
**   p ≤ 0.05






Missed opportunies are indicated in red
Figure 1 Comparison of the missed PMTCT opportunities in the “sdNVP”-group and the later “dual-therapy” group.
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proved significantly to 33% in the “dual-therapy” group
(p < 0.001), while the percentage of infants without ap-
propriate antiretroviral medication also meaningfully de-
creased from 72% to 32% (p < 0.001).
Maternal report of receiving inconsistent infant feed-
ing information from different health workers during
and after pregnancy was the only missed opportunity
that had significantly increased over time, from 18%
(“sdNVP”) to 32% (“dual-therapy”) (p = 0.05). At birth,
two-thirds of mothers had chosen to exclusively breastfeedtheir infants, with infant feeding counseling described as
inadequate in 21% (16/75) and 18% (23/126) respectively
(p = 0.59, NS). Twenty-five mothers (19%) had experi-
enced difficulty with breastfeeding initiation, while another
59% stated that they would have benefited from assistance
in establishing exclusive breastfeeding. Counseling had
been done in 70% regarding the increased risk of HIV
transmission through mixed feeding. Sixty-six mothers
(33%) opted for replacement feeds. Questions assessing
the suitability of this choice, by considering whether it had
been acceptable, feasible, affordable, sustainable and safe
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while 11% reported no counseling prior to commencing
formula feeding.
Postnatal care
The focus of the fourth PMTCT stage is on reduction of
postnatal HIV transmission and identification of HIV-
infected infants. Less than half of mother-infant pairs
had received healthcare in the first week after delivery,
with no improvement noted over time (“sdNVP” = 68%,
“dual-therapy” = 54%) (p = 0.58; NS). The majority of
HIV-exposed infants had received healthcare at 6 weeks,
which amounted to 89% and 92% respectively (p = 0.54,
NS), while in 38% of cases a different postnatal clinic
compared to the antenatal clinic had been visited. Cotri-
moxazole prophylaxis had not been given to 73% of
“sdNVP” infants, but this subsequently significantly im-
proved to 45% for the “dual-therapy” group (p < 0.001).
Mothers reported no or incomplete infant feeding coun-
seling at the six-week visit in 53% (40/75; “sdNVP”), which
improved significantly to 25% (32/126; “dual-therapy”)
(p < 0.001).
Initial HIV DNA PCR testing for infant diagnosis had
not been done in 48%, but with significant improvement
over time (“sdNVP” = 72% (54/75); “dual-therapy” = 34%
(43/126); p < 0.001). Nine mothers had not obtained
their infant’s HIV results. In 61% of the “sdNVP” group
the post-weaning HIV diagnostic test had not been done,
but this significantly improved to 39% (p < 0.01); failure
to do an HIV ELISA/rapid test at age 18 months signifi-
cantly improved from 64% to 44% (p < 0.01). Fifty-one
infants (37%) had been diagnosed HIV positive through
PMTCT testing (“sdNVP” = 10, “dual-therapy” = 41), but
five children had had no CD4 count, clinical staging and
referral for ART done, although the HIV DNA PCR had
been positive.
Discussion
The PMTCT program represents a continuum of health-
care towards prevention of pediatric HIV infection and
optimizing maternal-infant outcomes. The WHO encour-
aged a comprehensive PMTCT approach since 2002,
including primary HIV prevention, prevention of unin-
tended pregnancies in HIV-infected women, PMTCT,
along with care provision for HIV-positive women, their
infants and families [12]. Enhanced ART interventions
have since evolved, shifting the goalpost to “virtual elimin-
ation of pediatric HIV” or HIV transmission rates at <5%
set as the WHO target for 2015, which emphasizes the
need for renewed focus on health service improvements
to ensure the availability and the uptake of all PMTCT
components [13-16].
In this study we were able to show significant progress
over time for several PMTCT elements, as demonstratedthrough improved maternal HIV diagnosis, ART inter-
ventions and infant diagnosis. However, this study iden-
tified missed opportunities in all four PMTCT stages,
and in some of the steps optimal PMTCT was missed in
more than half of cases, collectively increasing children’s
risk of HIV acquisition. Despite emphasis towards pro-
moting the PMTCT continuum, which requires inter-
ventions to commence even before pregnancy, reports
indicate disappointing progress at implementation level
regarding the pre-conceptual components [14]. Primary
prevention strategies need high priority, which includes
targeted HIV testing of women of childbearing age. This
study demonstrated that less than one in five mothers
were aware of their HIV infection before pregnancy,
which correlates with another South African study,
where only 12% of mothers of newly diagnosed HIV-
infected children were aware of their own HIV infection
prior to conception [17]. Known HIV status before preg-
nancy was previously proven to translate into higher
PMTCT uptake and early infant testing [17]. Further-
more, almost a third of our study mothers reported diffi-
culties in accessing family planning services, while more
than half reported unplanned pregnancies, indicating
that these pre-conceptual PMTCT steps require urgent
attention. Linking HIV- and family-planning services is
feasible and effective in reducing vertical HIV transmis-
sion and has proven to be more cost effective than ART
interventions. However, most PMTCT programs con-
tinue to place the main emphasis on ART provision, as
previously reported [15,18,19].
During pregnancy, routine healthcare and PMTCT in-
terventions can readily be linked, especially when ante-
natal care utilization rates are high, like in South Africa
[17]. Such linking can then translate into increased ante-
natal HIV testing with subsequent CD4 counts, which
was confirmed in our study. However, HIV testing was
done in the second trimester or later in two-thirds of
our study women, limiting timely PMTCT interventions
and indicating the need to focus on early pregnancy
bookings. Additionally the overlapping HIV and TB epi-
demics pose a serious threat to HIV-infected women
and their offspring, but TB screening during pregnancy
was not carried out in two thirds of the study group, point-
ing towards a further urgent need [20]. Previous research
indicates increased TB rates in HIV-positive pregnant
women compared to HIV-uninfected women [21], while
HIV/TB co-infection during pregnancy potentiates the risk
of both HIV- and TB transmission to the infants [22,23].
To ensure optimal medical management and to meet
specific client needs, individualization of patient man-
agement should be maintained as far as possible, even
within large public health programs like PMTCT. Study
participants reported inadequate psychosocial support,
with no improvement over time, which is of concern as
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received their HIV diagnosis during pregnancy, adding
to known emotional and financial stresses associated
with pregnancy and child birth [24]. High maternal de-
pression rates have previously been described in HIV-
infected pregnant women [25], while infants of mothers
with mental illnesses are at risk of insufficient maternal
care and poor growth [26,27]. This indicates the need to
integrate psychosocial support and mental health ser-
vices into antenatal care. Non-disclosure of HIV status,
reported by two-thirds of study participants, is associ-
ated with non-attendance of HIV services as well as
non-adherence to maternal-infant ART regimens, as
previously described in Sub-Saharan Africa [24,28]. A
previous South African study found the current PMTCT
approach to have a strong focus on the pregnant woman
as an individual, with very little male participation, cor-
relating with our findings that 72% of mothers did not
know their partner’s HIV status, nor was sibling HIV
testing done in 61% of families, clearly indicating the
need for a more family-centered approach [11,14,29].
Continuity of care between pregnancy and delivery
services is vital to ensure that health workers providing
care during the birth process are aware of maternal HIV
infection and prior interventions. A previous South Afri-
can report indicated this to be problematic, because of
ineffective record keeping (such as use of HIV coding
systems on health records) and because health workers
did not enquire about HIV or mothers did not report
their HIV-status [30]. We recorded significant improve-
ment over time in terms of the maternal HIV diagnosis
being known at time of delivery, with improved
maternal-infant ART provision. Continued emphasis on
meticulous record keeping is needed, along with social
mobilization to increase the client demand for appropri-
ate services [30]. Discontinuation of HIV care for
mothers after pregnancy has also been described in sub-
Saharan Africa [28,31]. Many (59%) of our mother-infant
pairs received no healthcare in the postnatal period, a
time known to be associated with a high risk of maternal
and neonatal mortality. The six-week infant immuniza-
tion visit, though, was well attended (>90%), but con-
tinuity of care may have been compromised, as many
mothers visited different clinics post-delivery compared
to their antenatal clinics, with potential loss of informa-
tion between different providers. Half of the study
mothers also chose to visit traditional healers, which is a
finding of note, as these services fall mostly outside of
the national PMTCT framework (and previously de-
scribed in another South African study) [32].
Infant feeding counseling, straddling the antenatal and
postnatal periods, should assist mothers in making in-
formed choices on safe feeding. Consistent infant feeding
information was the only PMTCT component whichsignificantly worsened over time in this study, which is
similar to the maternal confusion about infant feeding
described in another study in Soweto, South Africa [33].
This reflects on the transition period, in which expand-
ing scientific knowledge on ART prophylaxis for breast-
feeding mothers led to adjustments in clinical practice
and ultimately to changes in guidelines, without coord-
ination at implementation level. Many women (78%) in
our study voiced the need for practical help with breast-
feeding initiation, clearly indicating that maternal sup-
port is essential to ensure that exclusive breastfeeding is
established in all mothers [34]. Mothers who opted for
formula feeding could not do so safely in 68%, placing
infants at risk of associated morbidity [35,36].
Early identification of HIV-infected infants is essential
to optimize childhood outcome, but this remains chal-
lenging. According to the National Guidelines HIV DNA
PCR testing should be done on all HIV-exposed children
at the age of 6 weeks, followed by an age-appropriate
HIV-test after weaning and an HIV ELISA/rapid test at
18 months [5]. We demonstrated improvements in HIV
testing at all three time points, correlating with pub-
lished South African data [3], although full coverage has
not been reached. HIV-infected children that are not
identified during the PMTCT process may have delayed
pediatric ART initiation, with resultant high HIV-related
infant mortality [14,37]. HIV-exposed children as a risk
group also need additional healthcare to mitigate the
many well described health risks, such as increased rates
of gastrointestinal and respiratory infections [38,39].
Among others, they should receive cotrimoxazole prophy-
laxis for prevention of early opportunistic infections,
which did improve over time as demonstrated in this study
(from 27% to 55%), but coverage remained suboptimal.
Study limitations were that information was self-
reported by primary caregivers, which in 16% was not
the mother. Recall bias may have been more pronounced
in the earlier “sdNVP”-group, due to the longer time
lapse since PMTCT participation. Verbal information
was validated using hospital records, patient-held re-
cords and laboratory databases as far as possible. Lan-
guage barriers during interviews were mitigated through
the use of translators. Study group allocation occurred
according to date of birth; however, pregnancies last
nine months and updated PMTCT protocols do not
change overnight at implementation date; therefore,
group allocation in those born during the transition be-
tween the two defined periods may have had limitations.
Furthermore this was a hospital based study, with two-
thirds of study participants being HIV infected and
therefore had failed PMTCT, with high probability of
missed PMTCT opportunities. As this was not a popula-
tion based study, the results are thus not generalizable
for all children from the PMTCT program of the time,
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this study design.
For further improvement of PMTCT services, health
systems should be improved [16,19]. Rapid implementa-
tion of a large-scale public health intervention such as
PMTCT should be followed by full integration into rou-
tine health services [40]. Missed opportunities must be
identified and addressed.
Conclusions
This study has identified missed opportunities for HIV
prevention among South African children using the four
PMTCT stages outlined in the National Guidelines. The
data has demonstrated significant improvements in ante-
natal PMTCT enrolment, known maternal HIV diagno-
sis at delivery, mother-infant ART interventions and
infant HIV diagnosis, indicating PMTCT focus areas that
have succeeded. A lot still needs to be done to improve
preconception HIV services linked to family planning
services, TB screening in pregnancy, HIV disclosure,
psychosocial support, postnatal care, including infant
feeding support, in order to reach the ultimate goal of
pediatric HIV elimination.
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